Home › Medivir: MIV-802 has been selected as a candidate drug and enters...
 

Keywords :   


Medivir: MIV-802 has been selected as a candidate drug and enters...

2014-12-22 13:31:25| Appliances - Topix.net

Medivir AB announced that MIV-802 has been selected as a candidate drug from its hepatitis C virus nucleotide polymerase inhibitor project for the treatment of HCV infection, and is entering non-clinical development. Approximately 120 million people are chronically infected with HCV globally*.

Tags: selected drug candidate enters

Category:Consumer Goods and Services

Latest from this category

All news
23.11'Trust and reserve judgement' on rebrand, says Jaguar
23.11UK wants to hire EU negotiator to 'reset' relations
23.11Sisters build global beauty brand from a garage
23.11Versace bag for 15: Why Christmas shoppers are choosing charity shops
23.11'We are being robbed': Homeowners feel trapped by rising fees
22.11'Scammers sent courier to steal 4,000'
22.11Spain fines budget airlines including Ryanair 179m
22.11Formulating Biphasic and Triphasic Products
Consumer Goods and Services »
24.11STEINBACH40
24.11 Sepua Crue F-170
24.11 SECRET
24.11CRAwith
24.1111/15)&&
24.11 8
24.11
24.11F2023 23
More »